Safety and Efficacy of Autologous Mesenchymal Stem Cells in Chronic Spinal Cord Injury

NCT01676441 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped sponsor decision (confidential)

Conditions

Spinal Cord Injury

Interventions

DRUG: cellgram-spine

Sponsor

Pharmicell Co., Ltd.